Uncategorized
Oracle Missed On Cloud Revenue: Why AI ETFs Are Unfazed
calendar_month Jun 11, 2026, BY Chandrima Sanyal
Uncategorized
What’s Going On With AMC Entertainment Stock Thursday?
calendar_month Jun 11, 2026, BY Kaustubh Bagalkote
Harrow Adds Another Piece To Ophthalmology Strategy

Harrow Inc. (NASDAQ:HROW) on Wednesday announced the relaunch of VERKAZIA (cyclosporine ophthalmic emulsion) 0.1%, a prescription treatment for vernal keratoconjunctivitis (VKC), a serious allergic eye condition that primarily affects children. The eye care company said the move reflects its continued…

Uncategorized , calendar_month Jun 11, 2026
Why Is SanDisk Stock Gaining Thursday?

SanDisk Corporation (NASDAQ:SNDK) stock climbed nearly 6% on Thursday as investors continued to favor high-growth technology stocks amid a broader risk-on market environment. SanDisk continues to benefit from the AI infrastructure buildout, as rising demand for high-performance NAND storage and…

Uncategorized, calendar_month Jun 11, 2026
The Trade Desk Stock Hits 52-Week Lows: What’s Going On?

The Trade Desk Inc (NASDAQ:TTD) shares are trading lower on Thursday, hitting new 52-week lows as traders weigh a growth-rotation rebound narrative against a longer-term chart that's still in repair mode. Trade Desk shares are approaching critical lows. Why is…

Uncategorized, calendar_month Jun 11, 2026
Oracle Stock Collapse Hits Larry Ellison’s Wealth: Co-Founder Moves To Fifth Place, Behind Jeff Bezos

Oracle (NYSE:ORCL) reported record fourth quarter revenue and beat analyst estimates Wednesday night, but the stock fell on weaker-than-expected guidance. The stock's drop has made co-founder Larry Ellison worth significantly less and falling down the billionaires list. Larry Ellison's Wealth…

Uncategorized, calendar_month Jun 11, 2026
Why Is Humacyte Stock Falling Thursday?

Humacyte Inc. (NASDAQ:HUMA) stock plunged Thursday despite reporting positive interim Phase 3 data for its acellular tissue-engineered vessel (ATEV), as investors focused on a heavily dilutive stock offering announced alongside the clinical update. On Wednesday, Humacyte released interim Phase 3…